Penumbra Inc (PEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Penumbra Inc (PEN) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($46.08 Million) by net assets ($1.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Penumbra Inc for the company's overall valuation and market capitalisation.
Penumbra Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Penumbra Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Penumbra Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Penumbra Inc ranked by their cash flow conversion efficiency. Explore PEN cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grab Holdings Ltd
NASDAQ:GRAB
|
0.014x |
|
Turkiye Garanti Bankasi A.S.
IS:GARAN
|
0.249x |
|
SK Telecom Co Ltd
KO:017670
|
0.078x |
|
Xian LONGi Silicon Materials Corp
SHG:601012
|
0.045x |
|
One 97 Communications Limited
NSE:PAYTM
|
0.003x |
|
Graco Inc
NYSE:GGG
|
0.066x |
|
LPP S.A.
WAR:LPP
|
0.432x |
|
McCormick & Company Incorporated
NYSE:MKC
|
0.050x |
Annual Cash Flow Conversion Efficiency for Penumbra Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Penumbra Inc from 2013 to 2025. View latest Penumbra Inc stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.43 Billion | $238.66 Million | 0.167x | +14.20% |
| 2024-12-31 | $1.15 Billion | $168.48 Million | 0.146x | +77.31% |
| 2023-12-31 | $1.18 Billion | $97.33 Million | 0.083x | +248.16% |
| 2022-12-31 | $998.86 Million | $-55.66 Million | -0.056x | -659.43% |
| 2021-12-31 | $953.93 Million | $9.50 Million | 0.010x | +119.11% |
| 2020-12-31 | $637.79 Million | $-33.24 Million | -0.052x | -194.97% |
| 2019-12-31 | $485.61 Million | $26.65 Million | 0.055x | -19.52% |
| 2018-12-31 | $422.42 Million | $28.81 Million | 0.068x | +115.17% |
| 2017-12-31 | $400.41 Million | $12.69 Million | 0.032x | +165.97% |
| 2016-12-31 | $266.55 Million | $-12.81 Million | -0.048x | +49.85% |
| 2015-12-31 | $232.52 Million | $-22.28 Million | -0.096x | -118.55% |
| 2014-12-31 | $-12.37 Million | $-6.39 Million | 0.516x | +22.61% |
| 2013-12-31 | $-8.06 Million | $-3.40 Million | 0.421x | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more